SANTA ROSA, Calif. (PRWEB) November 15, 2017
Advera Health Analytics, Inc., a leader in pharmacovigilance software, analytics, and data at the forefront of drug safety science today announced that the VigiBase database of global individual case safety reports will now be available through its Evidex drug safety analytics platform.
VigiBase aggregates reports of adverse drug events from 110 countries, accounting for 90% of the world’s population. Developed and maintained by the Uppsala Monitoring Centre in Sweden, the dataset contains over 15 million reports of suspected adverse events submitted by health professionals, patients, and pharmaceutical companies going back to 1968. Case reports are coded to MedDRA to enable timely and accurate analysis.
Advera Health’s Evidex data aggregation platform is a scalable, flexible, and agile way for pharmacovigilance professionals in the healthcare industry to access and analyze drug safety data. Powered by the Advera’s proprietary RxFilter data optimization technology, Evidex supports a broad array of safety signal detection, signal management and risk mitigation use cases.
“We’re very excited to include the VigiBase global adverse event data in Evidex alongside our proprietary clinical trials safety outcomes data and our optimized post-approval data from FDA’s Adverse Event Reporting System (FAERS),” said Brian M. Overstreet, president & CEO of Advera Health Analytics. “While we’ve long focused on the U.S. adverse event data available from FAERS, our new relationship with Uppsala Monitoring Centre will allow us to provide clients with a global perspective on new and emerging safety issues across borders. This development brings us further toward what we’ve been calling Pharmacovigilance 2.0 – the next generation of signal detection, management, and mitigation from multiple real world data sources. Having Vigibase’s data on the Evidex platform will enable our clients to engage across various data sets in a dynamic and proactive manner.
For those interested in learning more, Advera Health has set up an information and inquiry web site specifically for the VigiBase data: https://info.adverahealth.com/evidex-vigibase-integration
About Advera Health Analytics
Advera Health Analytics is a global leader in pharmacovigilance software, analytics, and data at the leading edge of drug safety science. Founded in 2010 by a group of passionate healthcare entrepreneurs, Advera Health’s mission is to mitigate risk in the healthcare system by improving the transparency and actionability of drug safety data through the curation and aggregation of large disparate datasets and the application of proprietary analytics. Please visit http://www.adverahealth.com as well as our newsroom, blog, Twitter, and LinkedIn pages for more information about the company.
Advera Health’s Evidex® is a drug safety data aggregation platform that makes disparate drug safety data actionable though a simple to use yet powerful web-based application, empowering use at all organizational levels. Evidex is the gold standard resource for drug safety knowledge and insight, generated through proprietary curated data and analytics and powerful data integrations, enabling previously unavailable in-depth, rigorous adverse event analysis.